Drug intelligence / Profile preview

Fuyanping suppository

Development stage: Unknown
Lead developer: Shaanxi Dongtai Pharmaceutical
Administration: Vaginal

Overview

Fuyanping suppository (妇炎平栓) is a Traditional Chinese Medicine (TCM) vaginal suppository developed and manufactured by Shaanxi Dongtai Pharmaceutical. It is indicated for the treatment of various forms of vaginitis, including trichomonal vaginitis, fungal (candidal) vaginitis, and bacterial vaginosis. The formulation typically leverages the antimicrobial, anti-inflammatory, and cooling properties of traditional Chinese herbs to alleviate symptoms such as itching, discharge, and local irritation. It is an approved pharmaceutical product in China, designed for local administration to provide targeted relief and pathogen clearance within the vaginal environment.

Brand names: 妇炎平栓Fuyanping Suppository
Other names: Fuyanping Shuan

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Fuyanping suppository.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fuyanping suppository.

Explore the full profile